number of downloads : ?
language
eng
Author
Inoue Daisuke Third Department of Medicine, Teikyo University Chiba Medical Center, 3426-3, Anesaki, Ichihara-shi, Chiba, 299-0111, Japan
Muraoka Ryoichi Data Science Group, Clinical Development Department, Ajinomoto Pharmaceuticals Co., Ltd., Tokyo, Japan
Okazaki Ryo Third Department of Medicine, Teikyo University Chiba Medical Center, 3426-3, Anesaki, Ichihara-shi, Chiba, 299-0111, Japan
Nishizawa Yoshiki Department of Metabolism, Endocrinology, and Molecular Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan
Subject
Bisphosphonate; Risedronate; Metabolic syndrome; Life style-related disease; Bone mineral density; Bone turnover markers
Journal Title
CALCIFIED TISSUE INTERNATIONAL
Volume
98
Issue
2
Start Page
114
End Page
122
ISSN
0171-967X
ISSN(Online)
1432-0827
Published Date
2016-02
DOI
PubMed ID
Publisher
SPRINGER
NII Type
Journal Article
OAI-PMH Set
Faculty of Medicine
Remark
This study was supported by the Joint Development Program of Ajinomoto Pharmaceuticals Co., Ltd. and Takeda Pharmaceutical Co., Ltd. Funding for writing/editorial support was provided by Ajinomoto Pharmaceuticals Co., Ltd.
このエントリーをはてなブックマークに追加